Equity Analysis /
United States of America

US : Allogene Therapeutics, Inc. - ALLO | Analysis of Update on ALLO-501 & 501A

    Dane Leone
    Bowen Wu
    Bowen Wu

    Res. Assoc.

    CGS-CIMB
    20 May 2021
    Published by